CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
about
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentialsLinear ubiquitination in immunityAssociation of nuclear-localized Nemo-like kinase with heat-shock protein 27 inhibits apoptosis in human breast cancer cells.Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinoma.Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway.The roles of endoplasmic reticulum overload response induced by HCV and NS4B protein in human hepatocyte viability and virus replication.CYLD negatively regulates nontypeable Haemophilus influenzae-induced IL-8 expression via phosphatase MKP-1-dependent inhibition of ERK.CYLD-mediated signaling and diseases.Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: study on a chemically-induced HCC mouse model.Deubiquitinases in cancer.Downregulation of miR-362-5p inhibits proliferation, migration and invasion of human breast cancer MCF7 cellsCYLD Promotes TNF-α-Induced Cell Necrosis Mediated by RIP-1 in Human Lung Cancer Cells.Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression.Cylindromatosis--A Protective Molecule against Liver Diseases.CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.The expression of tumor suppressor gene Cyld is upregulated by histone deacetylace inhibitors in human hepatocellular carcinoma cell lines.Epidermal CYLD inactivation sensitizes mice to the development of sebaceous and basaloid skin tumors.miR‑197‑3p‑induced downregulation of lysine 63 deubiquitinase promotes cell proliferation and inhibits cell apoptosis in lung adenocarcinoma cell lines.Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.
P2860
Q26824909-E82413D3-ACDC-488C-9ABC-65074914C35CQ28082899-58D51A1A-0310-471A-AC3D-31065280887CQ33590271-4129CC27-6E6B-4079-ABC5-5EEC0C5E7880Q34352254-4F94F05F-EEA6-4C32-AF01-E77CBF581E1BQ35289238-CCD806A0-9E61-4035-93E7-646C01E8CAE6Q35393817-3F7722A4-69BE-4033-8720-16035F34600AQ35412516-6A58D496-B0B0-43A9-9C9B-29F0A3905F9CQ35565726-E04FB3C5-19F9-48BF-9C41-B2A676966B49Q35865032-38D3C0B2-02D8-4A0A-865C-65875859BAEBQ35955141-9393CC22-2F78-461E-AD89-D90A1AE58D80Q36524131-A5EDF825-E1C7-4951-85F3-7087F3EDA8DCQ37322774-E85686E7-2A3E-4777-9213-2F6D7B3931EBQ38261073-1782EC4E-E750-42D6-BC51-C4B52AC44D65Q38695458-3679D26C-00FD-4083-8B19-B9D7486FB89DQ38736933-2B5932DD-375C-4D3A-BB87-8D7470C4E6A8Q38749473-4DDFBE25-C96D-4EF1-87D9-FE7B368D4348Q42393322-7F8EE3C7-CA65-4B06-8A61-7EDFC1ADE628Q49500727-133AC9FD-4AA8-4C84-9AD2-13652925ADCFQ51653926-829BD4A3-406E-47B5-B76E-CDF496633E1B
P2860
CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
CYLD controls c-MYC expression ...... y in hepatocellular carcinoma.
@en
CYLD controls c-MYC expression ...... y in hepatocellular carcinoma.
@nl
type
label
CYLD controls c-MYC expression ...... y in hepatocellular carcinoma.
@en
CYLD controls c-MYC expression ...... y in hepatocellular carcinoma.
@nl
prefLabel
CYLD controls c-MYC expression ...... y in hepatocellular carcinoma.
@en
CYLD controls c-MYC expression ...... y in hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
CYLD controls c-MYC expression ...... y in hepatocellular carcinoma.
@en
P2093
Christoph Dorn
Claus Hellerbrand
Kristofer Ahlqvist
Rajeswara Rao Pannem
Ramin Massoumi
P2860
P304
P356
10.1093/CARCIN/BGT335
P407
P577
2013-10-08T00:00:00Z